Biotech · Private company
Entegrion, Inc.
Track this companyFree. Adds Entegrion, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- FP24 (Frozen Plasma)Phase 2 · CoagulopathyClinicalTrials.gov · fetched Nov 12, 2026
- ResusixPhase 2 · CoagulopathyClinicalTrials.gov · fetched Nov 12, 2026
- PCMCoagulationClinicalTrials.gov · fetched Nov 12, 2026
- PCM and ROTEMHemostasis MonitoringClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired CoagulopathyPHASE2 · TERMINATED · started Dec 14, 2018ClinicalTrials.gov NCT03700723 · fetched Nov 12, 2026
- Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation ParametersUNKNOWN · started Aug 20, 2018ClinicalTrials.gov NCT03679286 · fetched Nov 12, 2026
- Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy VolunteersUNKNOWN · started Apr 4, 2017ClinicalTrials.gov NCT03133351 · fetched Nov 12, 2026